000 01171 a2200337 4500
005 20250513212449.0
264 0 _c20000602
008 200006s 0 0 eng d
022 _a0007-1048
024 7 _a10.1046/j.1365-2141.2000.01901.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaker, P
245 0 0 _aAla-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin.
_h[electronic resource]
260 _bBritish journal of haematology
_cMar 2000
300 _a663 p.
_bdigital
500 _aPublication Type: Case Reports; Comment; Letter
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aFactor IX
_xgenetics
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPoint Mutation
650 0 4 _aWarfarin
_xadverse effects
700 1 _aClarke, K
700 1 _aGiangrande, P
700 1 _aKeeling, D
773 0 _tBritish journal of haematology
_gvol. 108
_gno. 3
_gp. 663
856 4 0 _uhttps://doi.org/10.1046/j.1365-2141.2000.01901.x
_zAvailable from publisher's website
999 _c10798967
_d10798967